Hong-Bin Sun

Title: Innovations of Hong-Bin Sun in Medicinal Chemistry

Introduction

Hong-Bin Sun is a notable inventor based in Nanjing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic applications. His work focuses on creating innovative solutions for health-related issues, particularly those involving platelet aggregation.

Latest Patents

Hong-Bin Sun holds a patent for "Optically active 2-hydroxy tetrahydrothienopyridine derivatives, preparation method and use in manufacture of medicament thereof." This patent describes optically active 2-hydroxytetrahydrothienopyridine derivatives represented by Formula I and their pharmaceutically acceptable salts. The preparation method and their use in the manufacture of a medicament are also disclosed. The pharmacodynamic experiment results indicate that the compounds of Formula I are effective in inhibiting platelet aggregation. Furthermore, pharmacokinetic studies show that these compounds can be converted in vivo into pharmacologically active metabolites, making them useful for preventing or treating thrombosis and embolism-related diseases.

Career Highlights

Hong-Bin Sun is currently associated with Jiangsu Vcare Pharma Tech Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has garnered attention for its potential impact on medical treatments and patient care.

Collaborations

He collaborates with talented coworkers, including Jiaqi Shan and Boyu Zhang, who contribute to the research and development efforts at their company.

Conclusion

Hong-Bin Sun's contributions to medicinal chemistry, particularly through his patented innovations, highlight his role as a key figure in the development of new therapeutic agents. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in the treatment of serious health conditions.